search of novel promising anti-inflammatory agents among the insufficiently known 3'-R-10'-R1-spiro[hetaryl-3(4),6'-[1,2,4]triazino[2,3-c]quinazolin]-2'(7'H)-ones. The virtual combinatorial library of previously unknown spiro-condensed derivatives of [1,2,4]triazino[2,3-c]quinazolines was formed and promising COX-2 inhibitors were identified by molecular docking method. Potential anti-inflammatory
目前的工作致力于在未知的3'-R-10'-R1-spiro [hetaryl-3(4),6'-[1,2,4] triazino [ 2,3-c]
喹唑啉] -2'(7'H)-一。形成了以前未知的
[1,2,4]三嗪基[2,3-c]
喹唑啉螺旋稠合衍
生物的虚拟组合库,并通过分子对接方法鉴定了有希望的COX-2
抑制剂。通过取代的3-(2-
氨基苯基)-6-R-
1,2,4-三嗪-5(2H)-与杂环酮的[5 +1]-环缩合反应合成潜在的抗炎药。通过复杂的理化方法验证了合成化合物的结构,并讨论了光谱特征。使用
福尔马林诱导的爪
水肿模型研究获得的化合物的抗炎活性,并鉴定出高活性化合物。进行的
SAR分析表明,将三嗪基[2,3-c]
喹唑啉部分与螺缩合的片段结合使用是创建新型抗炎剂的合理方法。